![Steven E. Fleck](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Steven E. Fleck
Direttore Finanziario/CFO presso CDG Therapeutics, Inc.
Posizioni attive di Steven E. Fleck
Società | Posizione | Inizio | Fine |
---|---|---|---|
CDG Therapeutics, Inc.
![]() CDG Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology CDG Therapeutics, Inc. develops pharmaceutical products. Its peptides are derived from bacterial & plant sources and are selective for certain cancers while avoiding healthy cells. The company was founded by Ananda M. Chakrabarty and Tapas K. Das Gupta in May 2001 and is located in River Forest, IL. | Direttore Finanziario/CFO | 01/04/2006 | - |
Storia della carriera di Steven E. Fleck
Precedenti posizioni note di Steven E. Fleck
Società | Posizione | Inizio | Fine |
---|---|---|---|
Northfield Laboratories, Inc.
![]() Northfield Laboratories, Inc. BiotechnologyHealth Technology The Company's principal activity is to develop, manufacture, market and distribute a hemoglobin-based blood substitute product. The Company's product, PolyHeme(R) blood substitute, provides an alternative to transfused blood for use in the treatment of acute blood loss. The company uses a proprietary process of separation, filtration, chemical modification purification and formulation to produce PolyHeme. PolyHeme is designed to avoid potential undesirable effects such as vasoconstriction, kidney dysfunction, liver dysfunction and gastrointestinal distress. Clinical trials of PolyHeme have been conducted at multiple locations in the United States. The company has entered into license agreements with Pfizer Inc and Hemocare Ltd an Israeli corporation to develop manufacture and distribute PolyHeme in certain European, Middle Eastern and African countries. The Company is in development stage. | Comptroller/Controller/Auditor | 01/01/1998 | 01/01/2005 |
Formazione di Steven E. Fleck
University of Illinois | Undergraduate Degree |
Northern Illinois University | Masters Business Admin |
Statistiche
Distribuzione geografica
Stati Uniti | 5 |
Posizioni
Director of Finance/CFO | 1 |
Undergraduate Degree | 1 |
Masters Business Admin | 1 |
Settori
Health Technology | 3 |
Consumer Services | 3 |
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Società collegate
Aziende private | 2 |
---|---|
CDG Therapeutics, Inc.
![]() CDG Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology CDG Therapeutics, Inc. develops pharmaceutical products. Its peptides are derived from bacterial & plant sources and are selective for certain cancers while avoiding healthy cells. The company was founded by Ananda M. Chakrabarty and Tapas K. Das Gupta in May 2001 and is located in River Forest, IL. | Health Technology |
Northfield Laboratories, Inc.
![]() Northfield Laboratories, Inc. BiotechnologyHealth Technology The Company's principal activity is to develop, manufacture, market and distribute a hemoglobin-based blood substitute product. The Company's product, PolyHeme(R) blood substitute, provides an alternative to transfused blood for use in the treatment of acute blood loss. The company uses a proprietary process of separation, filtration, chemical modification purification and formulation to produce PolyHeme. PolyHeme is designed to avoid potential undesirable effects such as vasoconstriction, kidney dysfunction, liver dysfunction and gastrointestinal distress. Clinical trials of PolyHeme have been conducted at multiple locations in the United States. The company has entered into license agreements with Pfizer Inc and Hemocare Ltd an Israeli corporation to develop manufacture and distribute PolyHeme in certain European, Middle Eastern and African countries. The Company is in development stage. | Health Technology |
- Borsa valori
- Insiders
- Steven E. Fleck
- Esperienza